pubmed· e01.org

PubMed · PMID 20797828

CD4+ CD25(high) regulatory T cell in childhood ocular myasthenia gravis.

PMID 20797828Journal Brain & developmentYear 2011Authors 7DOI 10.1016/j.braindev.2010.08.002

  • Source PubMed
  • Journal Brain & development
  • Year 2011
  • Authors Hiroshi Sakuma; Ayako Katayama; Yoshiaki Saito; Hirofumi Komaki; Eiji Nakagawa; Kenji Sugai; Masayuki Sasaki
  • Licence NLM/PubMed terms

Abstract

Dysfunction of CD4(+)CD25(+) regulatory T cell (Treg) has been demonstrated to play an important role in the development of autoimmune myasthenia gravis. This T cell subset, which has potent regulatory properties against immune response, has been reported to have a numerical or functional defect in patients with myasthenia gravis. We examined various T cell subsets, including CD4(+)CD25(+)Treg in peripheral blood mononuclear cells using flow cytometry in a pediatric patient suffering from ocular myasthenia gravis. Contrary to previous reports, the percentage of CD4(+)CD25(+)Treg in peripheral blood decreased significantly after successful treatment with prednisolone.

This discrepancy could result from diversity within the immunopathogenesis of myasthenia gravis and may underpin a particular subgroup of myasthenia gravis seen in the East-Asian pediatric population.

Record details

PMID20797828
PMCIDnot held
DOI10.1016/j.braindev.2010.08.002
JournalBrain & development
Year2011
AuthorsHiroshi Sakuma; Ayako Katayama; Yoshiaki Saito; Hirofumi Komaki; Eiji Nakagawa; Kenji Sugai; Masayuki Sasaki
Licencenot stated
MeSHCD4 Antigens; Child, Preschool; Female; Humans; Interleukin-2 Receptor alpha Subunit; Lymphocyte Subsets; Myasthenia Gravis; T-Lymphocytes, Regulatory

Source record

Open the PubMed record. This page holds the abstract and citation fields for this PMID; no PMC full text is held for it.

Source
PubMed / NLM
PMID
20797828
Rendered
2026-11-22
Completeness
abstract and citation fields